Eli Lilly’s .25B acquisition of Kelonia Therapeutics caps startup’s tortuous ride

Eli Lilly’s $3.25B acquisition of Kelonia Therapeutics caps startup’s tortuous ride

Eli Lilly is spending $3.25 billion to accumulate Kelonia Therapeutics, a small biotech firm growing cell therapies for most cancers and autoimmune ailments, the businesses introduced Monday.  Lilly might pay extra if Kelonia achieves specified scientific, regulatory, and business milestones.  The acquisition is a boon for the small startup, which has subsisted on $60 million…

Read More
Anthropic’s New Product Aims to Handle the Hard Part of Building AI Agents

Anthropic’s New Product Aims to Handle the Hard Part of Building AI Agents

Anthropic introduced Wednesday the launch of a brand new product that goals to make it simpler for companies to construct and deploy AI agents. The instrument, Claude Managed Agents, presents builders out-of-the-box infrastructure to construct autonomous AI methods, simplifying a posh course of that was beforehand a barrier to automating work duties. The transfer positions…

Read More